---
figid: PMC3225020__10.1177_1758834011423403-fig1
figlink: /pmc/articles/PMC3225020/figure/fig1-1758834011423403/
number: Figure 1
caption: Schematic representation of the c-MET (mesenchymal–epithelial transition
  factor) dependent signaling pathway. Activation of c-MET results in the recruitment
  of several SH2-domain-containing signal transducers that in turn activate a number
  of pathways, including the GRB2–SOS–RAS–RAF–MEK–ERK axis, leading to cell proliferation
  and invasion []. Strategies to inhibit c-MET signaling have therefore targeted different
  steps involved in c-MET activation. Ab, antibody; HGF, hepatocyte growth factor.
pmcid: PMC3225020
papertitle: 'In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs.'
reftext: Neelesh Sharma, et al. Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S37-S50.
pmc_ranked_result_index: '80232'
pathway_score: 0.9628231
filename: 10.1177_1758834011423403-fig1.jpg
figtitle: The c-MET (mesenchymal–epithelial transition factor) dependent signaling
  pathway
year: '2011'
organisms: Homo sapiens
ndex: 667177b1-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3225020__10.1177_1758834011423403-fig1.html
  '@type': Dataset
  description: Schematic representation of the c-MET (mesenchymal–epithelial transition
    factor) dependent signaling pathway. Activation of c-MET results in the recruitment
    of several SH2-domain-containing signal transducers that in turn activate a number
    of pathways, including the GRB2–SOS–RAS–RAF–MEK–ERK axis, leading to cell proliferation
    and invasion []. Strategies to inhibit c-MET signaling have therefore targeted
    different steps involved in c-MET activation. Ab, antibody; HGF, hepatocyte growth
    factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAF1
  - NRAS
  - HRAS
  - SOS1
  - MAP2K2
  - ARAF
  - MET
  - SOS2
  - KRAS
  - HGF
  - BRAF
  - MAP2K1
  - GRB2
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: c-MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
